{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:06:15Z","timestamp":1747368375514,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"DOI":"10.7759\/cureus.84156","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:55:57Z","timestamp":1747313757000},"source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Limbic Encephalitis in a Patient With Thymoma"],"prefix":"10.7759","author":[{"given":"Abdullah","family":"Alwohaibi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajd","family":"Althakfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatoon","family":"Bakhribah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123 ( Pt 7)","author":"Gultekin SH","year":"2000","unstructured":"Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000, 123 ( Pt 7):1481-94. 10.1093\/brain\/123.7.1481","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200229","article-title":"Comparative study of paraneoplastic and nonparaneoplastic autoimmune encephalitis with GABABR antibodies","volume":"11","author":"Lamblin F","year":"2024","unstructured":"Lamblin F, Kerstens J, Mu\u00f1iz-Castrillo S, et al.. Comparative study of paraneoplastic and nonparaneoplastic autoimmune encephalitis with GABABR antibodies. Neurol Neuroimmunol Neuroinflamm. 2024, 11:e200229. 10.1212\/NXI.0000000000200229","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus F","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al.. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016, 15:391-404. 10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01266.x","article-title":"Management of paraneoplastic neurological syndromes: report of an EFNS Task Force","volume":"13","author":"Vedeler CA","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, et al.. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006, 13:682-90. 10.1111\/j.1468-1331.2006.01266.x","journal-title":"Eur J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.744653","article-title":"Paraneoplastic and other autoimmune encephalitides: antineuronal antibodies, T lymphocytes, and questions of pathogenesis","volume":"12","author":"Greenlee JE","year":"2021","unstructured":"Greenlee JE, Carlson NG, Abbatemarco JR, Herdlev\u00e6r I, Clardy SL, Vedeler CA. Paraneoplastic and other autoimmune encephalitides: antineuronal antibodies, T lymphocytes, and questions of pathogenesis. Front Neurol. 2021, 12:744653. 10.3389\/fneur.2021.744653","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577285","article-title":"Searching for autoimmune encephalitis: beware of normal CSF","volume":"345","author":"H\u00e9bert J","year":"2020","unstructured":"H\u00e9bert J, Gros P, Lapointe S, et al.. Searching for autoimmune encephalitis: beware of normal CSF. J Neuroimmunol. 2020, 345:577285. 10.1016\/j.jneuroim.2020.577285","journal-title":"J Neuroimmunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001721","article-title":"Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study","volume":"85","author":"Gozzard P","year":"2015","unstructured":"Gozzard P, Woodhall M, Chapman C, et al.. Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study. Neurology. 2015, 85:235-9. 10.1212\/WNL.0000000000001721","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0429-z","article-title":"Paraneoplastic diseases associated with thymoma","volume":"254","author":"Evoli A","year":"2007","unstructured":"Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G, Lauriola L, Fattorossi A. Paraneoplastic diseases associated with thymoma. J Neurol. 2007, 254:756-62. 10.1007\/s00415-006-0429-z","journal-title":"J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/00313028809059510","article-title":"Limbic encephalitis associated with malignant thymoma","volume":"20","author":"McArdle JP","year":"1988","unstructured":"McArdle JP, Millingen KS. Limbic encephalitis associated with malignant thymoma. Pathology. 1988, 20:292-5. 10.3109\/00313028809059510","journal-title":"Pathology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2010.10.022","article-title":"Thymoma-associated paraneoplastic encephalitis (TAPE): diagnosis and treatment of a potentially fatal condition","volume":"141","author":"Erkmen CP","year":"2011","unstructured":"Erkmen CP, Fadul CE, Dalmau J, Erkmen K. Thymoma-associated paraneoplastic encephalitis (TAPE): diagnosis and treatment of a potentially fatal condition. J Thorac Cardiovasc Surg. 2011, 141:e17-20. 10.1016\/j.jtcvs.2010.10.022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma","volume":"10","author":"Vernino S","year":"2004","unstructured":"Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004, 10:7270-5. 10.1158\/1078-0432.CCR-04-0735","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f23f04","article-title":"Caspr2 antibodies in patients with thymomas","volume":"5","author":"Vincent A","year":"2010","unstructured":"Vincent A, Irani SR. Caspr2 antibodies in patients with thymomas. J Thorac Oncol. 2010, 5:S277-80. 10.1097\/JTO.0b013e3181f23f04","journal-title":"J Thorac Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani SR","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA, et al.. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012, 72:241-55. 10.1002\/ana.23577","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen A","year":"2016","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, et al.. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016, 87:521-8. 10.1212\/WNL.0000000000002917","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001053","article-title":"Thymoma and autoimmune encephalitis: clinical manifestations and antibodies","volume":"8","author":"Guasp M","year":"2021","unstructured":"Guasp M, Landa J, Martinez-Hernandez E, et al.. Thymoma and autoimmune encephalitis: clinical manifestations and antibodies. Neurol Neuroimmunol Neuroinflamm. 2021, 8:10.1212\/NXI.0000000000001053","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers","volume":"67","author":"Giometto B","year":"2010","unstructured":"Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010, 67:330-5. 10.1001\/archneurol.2009.341","journal-title":"Arch Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25294-y","article-title":"Paraneoplastic limbic encephalitis associated with lung cancer","volume":"8","author":"Shen K","year":"2018","unstructured":"Shen K, Xu Y, Guan H, et al.. Paraneoplastic limbic encephalitis associated with lung cancer. Sci Rep. 2018, 8:6792. 10.1038\/s41598-018-25294-y","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0266-8","article-title":"Multicentric Castleman's disease with voltage-gated potassium channel antibody-positive limbic encephalitis: a case report","volume":"15","author":"Rao VR","year":"2015","unstructured":"Rao VR, Lim LE, Fong D, Garga NI, Parko KL. Multicentric Castleman's disease with voltage-gated potassium channel antibody-positive limbic encephalitis: a case report. BMC Neurol. 2015, 15:4. 10.1186\/s12883-015-0266-8","journal-title":"BMC Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102536","article-title":"Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective","volume":"70","author":"Gougis P","year":"2024","unstructured":"Gougis P, Jochum F, Abbar B, et al.. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective. EClinicalMedicine. 2024, 70:102536. 10.1016\/j.eclinm.2024.102536","journal-title":"EClinicalMedicine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101011","article-title":"Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study","volume":"44","author":"Farina A","year":"2024","unstructured":"Farina A, Villagr\u00e1n-Garc\u00eda M, Fourier A, et al.. Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study. Lancet Reg Health Eur. 2024, 44:101011. 10.1016\/j.lanepe.2024.101011","journal-title":"Lancet Reg Health Eur"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331048-paraneoplastic-limbic-encephalitis-in-a-patient-with-thymoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:55:58Z","timestamp":1747313758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331048-paraneoplastic-limbic-encephalitis-in-a-patient-with-thymoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84156","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,15]]}}}